Ronald B. Kocak's most recent trade in RenovoRx Inc was a trade of 41,600 Stock Option done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Ronald B. Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 41,600 | 41,600 | - | - | Stock Option | |
| RenovoRx Inc | Ronald B. Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 166,400 | 166,400 | - | - | Stock Option | |
| RenovoRx Inc | Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 08 Apr 2025 | 6,500 | 12,595 | - | 0.8 | 5,135 | Common Stock |
| RenovoRx Inc | Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 08 Apr 2025 | 6,000 | 6,095 | - | 0.8 | 4,800 | Common Stock |
| RenovoRx Inc | Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 08 Apr 2025 | 95 | 95 | - | 0.8 | 76 | Common Stock |
| RenovoRx Inc | B. Ronald Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,000 | 15,000 | - | - | Options |